Kim Stecker

1.0k total citations
22 papers, 830 citations indexed

About

Kim Stecker is a scholar working on Molecular Biology, Surgery and Immunology and Allergy. According to data from OpenAlex, Kim Stecker has authored 22 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Immunology and Allergy. Recurrent topics in Kim Stecker's work include RNA Interference and Gene Delivery (9 papers), Cell Adhesion Molecules Research (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Kim Stecker is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Cell Adhesion Molecules Research (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Kim Stecker collaborates with scholars based in United States, Germany and Austria. Kim Stecker's co-authors include C. Frank Bennett, Madeline Butler, Scott P. Henry, David Monteith, Scott Cooper, Doug A. Brooks, Mark Graham, Randy B. Howard, Doug Kornbrust and William A. Hall and has published in prestigious journals such as Biomaterials, Methods in enzymology on CD-ROM/Methods in enzymology and British Journal of Cancer.

In The Last Decade

Kim Stecker

22 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Stecker United States 13 477 169 144 132 83 22 830
Alan R. Brooks United States 10 594 1.2× 162 1.0× 241 1.7× 138 1.0× 42 0.5× 19 975
Kenji Nagao Japan 15 478 1.0× 157 0.9× 126 0.9× 75 0.6× 43 0.5× 45 842
R. M. Sharrard United Kingdom 17 457 1.0× 121 0.7× 78 0.5× 78 0.6× 49 0.6× 31 866
Masanao Tsuda United States 9 536 1.1× 90 0.5× 127 0.9× 89 0.7× 57 0.7× 14 940
Dawn M. Bryce Canada 11 601 1.3× 83 0.5× 75 0.5× 71 0.5× 67 0.8× 15 792
Corinna Warburton Canada 13 649 1.4× 63 0.4× 179 1.2× 111 0.8× 39 0.5× 16 1.1k
Suresh Jivan Gadher Czechia 15 381 0.8× 89 0.5× 40 0.3× 88 0.7× 49 0.6× 37 856
Terra Potocky United States 14 550 1.2× 168 1.0× 55 0.4× 80 0.6× 150 1.8× 19 1.1k
S. Park-Snyder United States 10 492 1.0× 167 1.0× 66 0.5× 30 0.2× 51 0.6× 10 784
Chi Faucheu United States 10 1.0k 2.2× 200 1.2× 132 0.9× 107 0.8× 30 0.4× 12 1.3k

Countries citing papers authored by Kim Stecker

Since Specialization
Citations

This map shows the geographic impact of Kim Stecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Stecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Stecker more than expected).

Fields of papers citing papers by Kim Stecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Stecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Stecker. The network helps show where Kim Stecker may publish in the future.

Co-authorship network of co-authors of Kim Stecker

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Stecker. A scholar is included among the top collaborators of Kim Stecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Stecker. Kim Stecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stecker, Kim, et al.. (2011). Impact of the coxsackievirus and adenovirus receptor on the adenoma–carcinoma sequence of colon cancer. British Journal of Cancer. 104(9). 1426–1433. 30 indexed citations
2.
Stecker, Kim, et al.. (2009). Loss of Coxsackie and adenovirus receptor downregulates α-catenin expression. British Journal of Cancer. 101(9). 1574–1579. 12 indexed citations
4.
Danis, Ronald P., Mark H. Criswell, Faruk Örge, et al.. (2003). Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization. Current Eye Research. 26(1). 45–54. 18 indexed citations
5.
Ghobrial, R. Mark, Farin Amersi, Kim Stecker, et al.. (2001). Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplantation Proceedings. 33(1-2). 538–538. 5 indexed citations
6.
Stepkowski, S M, Wenhao Chen, C. Frank Bennett, et al.. (2001). Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplantation Proceedings. 33(7-8). 3705–3706. 10 indexed citations
7.
Chen, Wenhao, C. Frank Bennett, Thomas P. Condon, et al.. (2001). Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplantation Proceedings. 33(1-2). 854–854. 6 indexed citations
8.
Stepkowski, Stanislaw M., Wenhao Chen, Richard S. Geary, et al.. (2001). Development of an oral formulation for ICAM-1 antisense oligonucleotides. Transplantation Proceedings. 33(1-2). 387–387. 1 indexed citations
9.
Henry, Scott P., et al.. (2000). Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice. Journal of Pharmacology and Experimental Therapeutics. 292(2). 468–479. 121 indexed citations
10.
Katz, Stephen M., Frank Bennett, Kim Stecker, et al.. (2000). ICAM-1 Antisense Oligodeoxynucleotide Improves Islet Allograft Survival and Function. Cell Transplantation. 9(6). 817–828. 19 indexed citations
11.
Chen, Wenhao, C. Frank Bennett, Mouer Wang, et al.. (1999). PERFUSION OF KIDNEYS WITH UNFORMULATED "NAKED" INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES PREVENTS ISCHEMIC/REPERFUSION INJURY1. Transplantation. 68(6). 880–887. 27 indexed citations
12.
Chen, Wenhao, C. Frank Bennett, Duska Dragun, et al.. (1999). PERFUSION OF KIDNEYS WITH NAKED ICAM-1 ANTISENSE OLIGODEOXYNUCLEOTIDES PREVENTS ISCHEMIC-REPERFUSION INJURY. Transplantation. 67(7). S264–S264. 1 indexed citations
13.
Graham, Mark, David Monteith, Scott Cooper, et al.. (1998). In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration. Journal of Pharmacology and Experimental Therapeutics. 286(1). 447–458. 113 indexed citations
14.
Wang, Mouer, Thomas P. Condon, Kim Stecker, et al.. (1998). PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1. Transplantation. 66(6). 699–707. 54 indexed citations
15.
Manoharan, Muthiah, et al.. (1997). 2′- and 3′- Biotin Conjugated Nucleoside Building Blocks: Synthesis of Biotinylated Oligonucleotides. Nucleosides and Nucleotides. 16(7-9). 1411–1413. 4 indexed citations
16.
Bennett, C. Frank, Doug Kornbrust, Scott P. Henry, et al.. (1997). An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 280(2). 988–1000. 160 indexed citations
17.
Glass, James R., et al.. (1996). Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix. Biomaterials. 17(11). 1101–1108. 54 indexed citations
18.
Zipp, Frauke, et al.. (1995). Lamotrigine in Parkinson's disease — a double blind study. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 199–206. 14 indexed citations
19.
Baas, H., et al.. (1995). Fluctuations in Parkinson's disease. Pathogenetic significance of levodopa's cerebral pharmacokinetics and pharmacodynamics.. PubMed. 46. 367–79. 2 indexed citations
20.
Harper, John R., Robert C. Spiro, William A. Gaarde, et al.. (1994). [12] Role of transforming growth factor β and decorin in controlling fibrosis. Methods in enzymology on CD-ROM/Methods in enzymology. 245. 241–254. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026